The 20 Best Myositis Doctors Near Me in Bethesda, MD

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Elite provider by MediFind in the treatment of Myositis. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as an Elite provider by MediFind in the treatment of Myositis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Scleroderma.

Dr. Andrew Mammen, MD is a Neurology Specialist in Baltimore, MD. He is affiliated with Johns Hopkins Bayview Medical Center. Dr. Mammen is rated as an Elite provider by MediFind in the treatment of Myositis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Necrotizing Myopathy (NM). Dr. Mammen is board certified in MD State Medical License 2004-2023.

Iago Pinal is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Pinal is rated as an Elite provider by MediFind in the treatment of Myositis. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, Antisynthetase Syndrome, and Lung Transplant.

Eleni Tiniakou is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Tiniakou is rated as an Elite provider by MediFind in the treatment of Myositis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Necrotizing Myopathy (NM).

Dr. Clifton Bingham is a Professor of Medicine, Director of the Johns Hopkins Arthritis Center, Director of the Center for Patient-Centered Outcomes Research in Rheumatology, Deputy Director for Research in the Division of Rheumatology, and Co-Director of the Rheumatic Diseases Research Core Center. He received his M.D. from Columbia University, where he also completed his Internal Medicine residency. He trained as a Fellow in both Rheumatology and in Allergy and Clinical Immunology at the Brigham and Women’s Hospital. Before coming to Hopkins in 2005, he was on faculty at NYU Hospital for Joint Diseases, where he founded a pioneering clinical and translational research center in rheumatology. He now directs the Johns Hopkins Arthritis Center, a group of 8 rheumatologists, 2 nurses, and a large clinical and research staff that sees more than 4500 patient visits each year, an integrates research with clinical care. His clinical interests are in the care of people living with Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis. Dr. Bingham’s research experience has been diverse, and across the research continuum from bench to bedside. His early work focused on understanding the cytokine regulation of inflammatory mediator generation operative in rheumatologic and allergic diseases. He conducted prior translational research to better understand the role of initiating and amplifying pathways in RA, and has ongoing collaborations with several basic researchers to identify biomarkers for improved patient phenotyping and outcome prediction. Additional multidisciplinary clinical and translational work has focused on the role of periodontal disease and oral bacteria as triggers of RA. In the realm of clinical research, he has served as principal investigator and helped to design and analyze a number of NIH and industry-sponsored clinical trials of multiple agents in early to late phases of development for RA, psoriatic arthritis, and osteoarthritis. He has led several studies of the effects of biological and immunomodulatory therapies on responses to immunizations. A large amount of his current research is focused in the area of patient centered outcomes research, including patient reported outcome development, validation, and integration in clinical care. He serves as a member of the Executive Leadership Committee for the international Outcome Measures in Rheumatology (OMERACT) methodology group. He has authored more than 170 original research articles, reviews, and editorials, and 12 book chapters. He served as a Co-Editor for the journal of the American College of Rheumatology, Arthritis and Rheumatology, and as a reviewer for a number of rheumatology journals and national and international grant reviews. Dr. Bingham is rated as an Advanced provider by MediFind in the treatment of Myositis. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Myositis, and Psoriatic Arthritis. Dr. Bingham is board certified in American Board Of Internal Medicine.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is rated as an Advanced provider by MediFind in the treatment of Myositis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Pallister-Killian Mosaic Syndrome, Temple Syndrome, and Inclusion Body Myositis. Dr. Albayda is board certified in American Board Of Internal Medicine.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Advanced provider by MediFind in the treatment of Myositis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma. Dr. Hummers is board certified in American Board Of Internal Medicine.

Hyon Schneider is a Physiatrist practicing medicine in Havre De Grace, Maryland. Dr. Schneider is rated as an Advanced provider by MediFind in the treatment of Myositis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Sacroiliac Joint Disease, Herniated Disk, Myositis, and Macrophagic Myofasciitis.

Melody Chung is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Myositis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis. Dr. Chung is board certified in American Board Of Internal Medicine.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as an Experienced provider by MediFind in the treatment of Myositis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Cappelli is board certified in American Board Of Internal Medicine.

Neurologist Payam Mohassel specializes in myopathies, muscular dystrophies, and other hereditary neuromuscular disorders and is the co-director of the Johns Hopkins Myositis Center. Dr. Mohassel obtained his medical degree from the Johns Hopkins University School of Medicine, where he remained for a medical internship, residency training in neurology, and clinical fellowship training in neuromuscular medicine. He then joined the National Institute of Neurological Disorders and Stroke Neurogenetics branch as a clinical research fellow. Dr. Mohassel’s research focuses on translational studies on neuromuscular disorders, and it spans gene discovery efforts, mechanistic studies to identify therapeutic targets, and early phase interventional clinical trials. Dr. Mohassel is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Hereditary Sensory Neuropathy Type 1 (HSN1), and Hereditary Sensory and Autonomic Neuropathy Type 2. Dr. Mohassel is board certified in American Board Of Psychiatry And Neurology.

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy. Dr. Gelber is board certified in American Board Of Internal Medicine.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology.

Dr. Maximilian Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Director of the Cellular Therapy Program (Autoimmunity) in the Department of Medicine at the Johns Hopkins University School of Medicine. He received his medical degree from Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin (Germany) and completed his residency training in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded subspecialty training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital. His clinical interests lie in treating patients with systemic autoimmune diseases, including myositis, scleroderma, lupus, vasculitis, and inflammatory arthritis. Dr. Konig is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), and Periodontitis. Dr. Konig is board certified in American Board Of Internal Medicine.

Dr. Leung obtained her undergraduate degree in biochemical sciences from Harvard University. While attending medical school at Duke University, she completed a year-long research fellowship studying genetic markers of late-onset Alzheimer’s disease at the National Institute on Aging as part of the NIH Clinical Research Training Program. She completed her neurology residency and clinical neurophysiology fellowship at Stanford University Medical Center, and is currently a Ph.D. candidate in the graduate training program in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Leung joined the Center for Genetic Muscle Disorders at the Kennedy Krieger Institute as a translational research fellow in 2010 and was appointed to the faculty in 2014. Her clinic specializes in electromyography and the diagnosis and treatment of hereditary muscle diseases. Dr. Leung’s research focuses on the development of imaging biomarkers and outcome measures for muscle diseases. She is the principal investigator for a longitudinal cohort study of whole-body MRI in facioscapulohumeral muscular dystrophy. Dr. Leung is also a site principal investigator for the Ionis-DMPKRx trial, a phase Ib/IIa clinical trial of a novel RNA-based therapy for myotonic muscular dystrophy. Dr. Leung is rated as an Experienced provider by MediFind in the treatment of Myositis. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, and Dysferlinopathy. Dr. Leung is board certified in American Board Of Psychiatry And Neurology.

Dr. Antiochos sees patients in the Division of Rheumatology on the Bayview campus and conducts basic science research into the pathogenesis of rheumatic diseases in the Division's laboratory. Lab website: Brendan Antiochos MD. Dr. Antiochos is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Necrotizing Vasculitis, Sjogren Syndrome, and Vasculitis.

Nitasha Kumar is a Rheumatologist practicing medicine in Olney, Maryland. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Myositis. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Juvenile Primary Osteoporosis. Dr. Kumar is board certified in Rheumatology.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as an Experienced provider by MediFind in the treatment of Myositis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is board certified in American Board Of Internal Medicine.

Dr. Peter M. Abadir is a geriatrician and translational researcher at Johns Hopkins University. He serves as the Principal Investigator of the Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research, where he leads interdisciplinary initiatives to advance innovations in aging and resilience science. His clinical focus includes frailty, cognitive decline, and age-related conditions, while his translational research bridges molecular biology, bioengineering, and geriatrics. Dr. Abadir is an Associate Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine and holds a joint appointment in Electrical and Computer Engineering at the Whiting School of Engineering. He also directs the Molecular Measurement Core of the Johns Hopkins Older Americans Independence Center and co-directs the Clinical Translation and Validation Core for the Artificial Intelligence and Technology Collaboratory. He currently serves as Chair of the MD Admissions Committee for the Johns Hopkins School of Medicine, overseeing the selection of the next generation of leaders in medicine. Additionally, Dr. Abadir is the Deputy Editor of the Journal of the American Geriatrics Society and serves on several other journal editorial boards. Among his research contributions, Dr. Abadir was among the first to describe the presence of a mitochondrial angiotensin system, providing new insights into cellular energy metabolism and aging. His pioneering work has also focused on biomarkers for frailty and cognitive decline, including circulating mitochondrial DNA and inflammation-related pathways. Notably, his research on the use tof topical angiotensin system blockers has introduced novel approaches to wound healing in aging populations. Dr. Abadir is a recipient of the Nathan Shock Scholar in Aging Award and the Frederick L. Brancati Excellence in Mentoring Award. Additionally, he has received the Johns Hopkins Institute for Excellence in Education Leadership and Mentorship Award and was inducted into the Johns Hopkins Distinguished Teaching Society, reflecting his outstanding contributions to mentorship and education. Dr. Abadir co-founded the Johns Hopkins Gerotech Incubator Program, which integrates medicine, engineering, and technology to develop solutions that enhance the health and independence of older adults. LinkedInhttps://www.linkedin.com/in/peter-abadir-87401715/. Dr. Abadir is rated as an Experienced provider by MediFind in the treatment of Myositis. His clinical expertise encompasses Dementia, Alzheimer's Disease, Vasoconstriction, and Necrosis. Dr. Abadir is board certified in American Board Of Family Medicine.